title: Developing an HIV vaccine.
authors.affiliation: Duke Human Vaccine Institute, Duke Center for HIV/AIDS Vaccine Immunology-Immunogen Discovery, Duke University School of Medicine, Durham, NC, USA. barton.haynes@duke.edu burton@scripps.edu.
authors.forename: Barton F
authors.initials: BF
authors.lastname: Haynes
authors.affiliation: Department of Immunology and Microbiology, Scripps Center for HIV/AIDS Vaccine Immunology-Immunogen Discovery, International AIDS Vaccine Initiative Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA. barton.haynes@duke.edu burton@scripps.edu.|Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, MA, USA.
authors.forename: Dennis R
authors.initials: DR
authors.lastname: Burton
mesh_terms: D016915:AIDS Vaccines / Q000276:immunology*; D000818:Animals; D002986:Clinical Trials as Topic; D015699:HIV Envelope Protein gp120 / Q000235:genetics / Q000276:immunology; D015658:HIV Infections / Q000517:prevention & control* / Q000628:therapy; D016333:HIV Protease / Q000235:genetics / Q000276:immunology; D006801:Humans; D000071497:Immunogenicity, Vaccine; D051379:Mice; D055503:Protein Multimerization; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D014614:Vaccines, Synthetic / Q000276:immunology; D054301:gag Gene Products, Human Immunodeficiency Virus / Q000235:genetics / Q000276:immunology
chemical_list: D016915:AIDS Vaccines; D015699:HIV Envelope Protein gp120; D014614:Vaccines, Synthetic; D054301:gag Gene Products, Human Immunodeficiency Virus; D016333:HIV Protease